Harmony Biosciences Holdings Inc Share Price Today: Live Updates & Key Insights
Harmony Biosciences Holdings Inc share price today is $35.32, up -1.34%. The stock opened at $35.84 against the previous close of $35.8, with an intraday high of $35.84 and low of $35.235.
Harmony Biosciences Holdings Inc Share Price Chart
Harmony Biosciences Holdings Inc
Harmony Biosciences Holdings Inc Share Price Performance
Harmony Biosciences Holdings Inc Institutional Holdings
Harmony Biosciences Holdings Inc Market Status
Harmony Biosciences Holdings Inc Fundamentals
Market Cap 2072.56 M
PB Ratio 2.2162
PE Ratio 14.0392
Enterprise Value 1536.03 M
Total Assets 1271.63 M
Volume 585339
Harmony Biosciences Holdings Inc Company Financials
About Harmony Biosciences Holdings Inc & investment objective
Company Information Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also develops Pitolisant that is in Phase 3 clinical trial for the treatment of Prader-Willi Syndrome (PWS); in Phase 2 clinical trial to treat Myotonic Dystrophy (DM1); and is in Phase 2 clinical trials for the treatment of Pitolisant Gastro-Resistant (GR) and Pitolisant High-Dose (HD). In addition, the company's products under development include BP1.15205, an orexin 2 receptor agonist for the treatment of narcolepsy and other potential indications; and HBS-102, a melanin-concentrating hormone receptor type 1 (MCHR1) antagonist. Further, it develops ZYN-002 that is in a Phase 3 registrational trial for the treatment of Fragile X Syndrome; and 22q Deletion Syndrome, a disorder caused by a small missing piece on the long arm of the 22nd chromosome. Additionally, the company is developing EPX-100 (clemizole hydrochloride), a serotonin (5HT-2) receptor agonist to treat dravet syndrome and lenox-gastaut syndrome; EPX-200 (liquid formulation of lorcaserin), a selective 5HT-2C agonist to treat developmental and epileptic encephalopathies; CBS105 for the treatment-resistant narcolepsy; and CBS104 for refractory epilepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.
Organisation Biotechnology
Employees 293
Industry Biotechnology
CEO Dr. Jeffrey M. Dayno M.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Harmony Biosciences Holdings Inc FAQs
What is the share price of Harmony Biosciences Holdings Inc today?
The current share price of Harmony Biosciences Holdings Inc is $35.32.
Can I buy Harmony Biosciences Holdings Inc shares in India?
Yes, Indian investors can buy Harmony Biosciences Holdings Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Harmony Biosciences Holdings Inc shares in India?
You can easily invest in Harmony Biosciences Holdings Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Harmony Biosciences Holdings Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Harmony Biosciences Holdings Inc.
Can I buy fractional shares of Harmony Biosciences Holdings Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Harmony Biosciences Holdings Inc?
Harmony Biosciences Holdings Inc has a market cap of $2072.56 M.
In which sector does Harmony Biosciences Holdings Inc belong?
Harmony Biosciences Holdings Inc operates in the Biotechnology sector.
What documents are required to invest in Harmony Biosciences Holdings Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Harmony Biosciences Holdings Inc?
The PE ratio of Harmony Biosciences Holdings Inc is 14.04 and the PB ratio is 2.22.